PAVmed Inc. (PAVM)

NASDAQ: PAVM · USD

$2.17

+0.03 (+1.4%)· Recorded snapshot

Market cap	15.2M
Revenue (ttm)	112K
Net income (ttm)	-20.6M
EPS (ttm)	-$9.85
Shares out	7M
Volume	9,956
Beta	0.70

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 112K
Net income (ttm): -20.6M
EPS (ttm): -$9.85
Market cap: 15.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Держать

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-64.8

P25 n/aP50 n/aP75 n/a

ROIC-43.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All PAVM indicators

Market & fundamental data

Available fields

204

Groups with data

Currency

USD

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001624326
Company name	PAVmed Inc.
Country	United States
Country code	US
CUSIP number	70387R502
Earnings date	2026-11-12
Earnings time	bmo
Employees	41
Employees change	2
Employees growth	5.13%
Enterprise value	$28.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2014
Industry	Medical Devices
IPO date	2016-04-28
Is primary listing	Yes
Is SPAC	No
ISIN number	US70387R5028
Last 10-K release date	2026-03-27
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2026-01-02
Last stock split type	Reverse
Market cap	$15.2M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$2.17
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	PAVM
U.S. state	New York
Website	https://www.pavmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-454.03%
EV/Sales	249.66x
FCF / EV yield	-27.83%
FCF yield	-52%
Forward EV/Sales	90.2x
Forward P/S	48.27x
Industry forward P/E	19.81x
Industry P/E	39.28x
P/B ratio	0.43x
P/S ratio	133.61x
Price / tangible book value	0.48x
Sector forward P/E	23.53x
Sector P/E	51.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-220.54%
Operating margin	-23,841.96%
Pretax margin	-14,670.54%
Profit per employee	$-503,098
Revenue per employee	$2,732
ROA	-39.69%
ROA (5Y)	-73.92%
ROCE	-73.92%
ROE	-64.78%
ROIC	-43.29%
SBC / revenue	3,631.25%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	0
Net income growth quarters	1
Net income growth years	0
Revenue growth	-89.02%
Revenue growth (Q)	450%
Revenue growth (QoQ)	50%
Revenue growth 3Y	-48.08%
Revenue growth quarters	3
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-52,000
Depreciation and amortization	$79,000
EBIT	$-26.7M
EBITDA	$-26.6M
EPS	$-9.85
FCF per share	$-1.11
Financing cash flow	$7.6M
Free cash flow	$-7.8M
Free cash flow minus SBC	$-11.8M
Gross profit	$-247,000
Investing cash flow	$-52,000
Net borrowing	$3.9M
Net cash flow	$-220,000
Net income	$-20.6M
Operating cash flow minus SBC	$-11.8M
Operating income	$-26.7M
Revenue	$112,000
Stock-based compensation	$4.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-10.8
Book value per share	$4.98
Debt / equity	0.88
Interest coverage	-1,405.42
Long-term assets	$35.4M
Long-term liabilities	$16.8M
Net cash (debt)	$-13M
Net cash / market cap	-86.86%
Net debt / equity	0.67
Piotroski F-Score	2
Property, plant and equipment	$1.8M
Shareholders' equity	$19.3M
Tangible book value	$31.2M
Tangible book value per share	$4.98
Total assets	$40.2M
Total cash	$4.1M
Total debt	$17.1M
Total liabilities	$20.9M
WACC	3.83%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0
Current assets	$4.9M
Current liabilities	$4.1M
Current ratio	1.19
Inventory turnover	1.52
Net working capital	$-2.7M
Quick ratio	1
Working capital	$770,000
Working capital turnover	-0.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	18.99%
Dividend yield	0%
Shareholder yield	18.99%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-99.96%
10Y return CAGR	-53.64%
10Y total return	-99.95%
150-day SMA	$5.60
1D price change	1.4%
1M price change	-45.12%
1M total return	-45.12%
1W price change	-5.38%
1W total return	-5.38%
1Y price change	-84.3%
1Y return CAGR	-84.32%
1Y total return	-84.3%
20-day SMA	$2.44
200-day SMA	$6.64
3M price change	-59.42%
3M total return	-59.42%
3Y price change	-98.18%
3Y return CAGR	-72.33%
3Y total return	-97.88%
50-day SMA	$3.70
50-day SMA vs 200-day SMA	50under200
52-week high	$28.44
52-week high date	2026-01-21
52-week low	$1.84
52-week low date	2026-10-23
5Y price change	-99.92%
5Y return CAGR	-75.07%
5Y total return	-99.9%
6M price change	-74.88%
6M total return	-74.88%
All-time high	$6,858.00
All-time high date	2016-08-04
All-time low	$1.84
All-time low date	2026-10-23
Average true range (ATR)	$0.28
Average volume	21.6K
Beta (1Y)	1.2
Beta (2Y)	1.41
Beta (5Y)	0.7
Change from 52-week high	-92.37%
Change from 52-week low	17.94%
Change from all-time high	-99.97%
Change from all-time low	14.67%
Change from open	2.36%
Day's gap	-0.93%
Dollar volume	$21,605
High price	$2.17
Low price	$2.09
Monthly RSI	31.25
Open price	$2.12
Position in 52-week range	100%
Premarket change	0%
Premarket close	$2.14
Premarket price	$2.14
Previous close	$2.14
Price vs 150-day SMA	-62.31%
Price vs 20-day SMA	-13.67%
Price vs 200-day SMA	-68.22%
Price vs 50-day SMA	-42.96%
Relative volume	0.46
RSI	29.2
Sharpe ratio	-0.85
Sharpe ratio (3Y)	-0.65
Sharpe ratio (5Y)	-0.76
Sortino ratio	-1.49
Sortino ratio (3Y)	-1.03
Sortino ratio (5Y)	-1.14
Volume	10K
Weekly RSI	24.63
YTD price change	-68.15%
YTD total return	-68.15%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4.1M
Float percentage	58.47%
Shares change (QoQ)	296.6%
Shares change (YoY)	-18.99%
Shares held by insiders	23.02%
Shares held by institutions	7.71%
Shares outstanding	7M
Short % of float	0.31%
Short % of shares	0.18%
Short ratio	0.5 days

Deeper analysis on PAVM

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this PAVM report

Is a complete PAVM research report available?

No complete published report is available for PAVmed Inc. (PAVM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

PAVmed Inc. (PAVM)

Price

Financial snapshot

Fair-value bridge

Latest news · PAVM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PAVM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PAVM

Frequently asked questions